We report ischemic complications related to obstruction of the posterior communicating artery (PcomA) and suggest treatment strategies according to the angiographic characteristics of the PcomA and the posterior cerebral artery (PCA). Twenty-one patients with PcomA aneurysm who had initially undergone endovascular treatment and had an identifiable PcomA occlusion on immediate or follow-up angiography were enrolled. We classified PcomA aneurysm according to the characteristics of the PcomA and PCA (P1) on baseline angiography, as follows: type I was defined as PcomA aneurysm with an absent PcomA and a normal-sized P1. Type II was defined as a hypoplastic PcomA and a normal-sized P1. Type III was defined as a normal-sized PcomA and an absent P1. Type IV was defined as a normal-sized PcomA and a hypoplastic P1. Type V was a normal-sized PcomA and a normal-sized P1. Among all cases of PcomA obstruction, 15 (71.4%) were type II PcomA aneurysms, four were type IV, one was type III, and one was type V. Ischemic events related to PcomA obstruction occurred in three cases (type II, III and VI), which included two tuberothalamic infarctions (type III and IV) and one cortical infarction in the territory of the PCA (type II). Follow-up angiographies showed flow change in the PcomA in 14 cases. It is relatively safe to sacrifice type II PcomA if necessary. However, physicians should pay attention to unexpected flow changes, such as recanalization or occlusion of the PcomA, which are possible after treatment.
Introduction
A posterior communicating artery (PcomA) aneurysm is located in only the proximal portion of the PcomA, which is usually incorporated in the aneurysm. Depending on the configuration of the aneurysm and the PcomA, it is sometimes difficult to preserve PcomA patency surgically or endovascularly. Occlusion of the PcomA, especially the fetal posterior cerebral artery (PCA), can result in significant ischemic complications such as ipsilateral infarction of the territory surrounding the PCA and the thalamus, and some studies have demonstrated ischemic complications during treatment of PcomA aneurysms when the PcomA is sacrificed. 1, 2 The relationship between ischemic complications and obstruction of the PcomA is poorly understood in cases of PcomA aneurysm. The Alcock test is considered useful in evaluating collateral blood flow and predicting postoperative ischemic complications that may occur after sacrifice of the PcomA. 3 
Materials and methods
The clinical and radiological records of 166 patients with 170 aneurysms treated for a PcomA aneurysm with coil embolization from March 2003 to December 2014 were retrospectively reviewed. The definition of PcomA aneurysm is of the aneurysm located on the posterior communicating segment of the internal carotid artery (ICA) with aneurysmal neck arising from the PcomA. Twenty-one patients with PcomA aneurysms who had initially undergone endovascular treatment and had identifiable occlusion of the PcomA on immediate or follow-up angiography were enrolled. We collected patient data, including age, sex, rupture state, aneurysm size, neck size, complication, initial Hunt and Hess (HH) grade, modified Rankin Scale score (mRS) at the last angiographic follow-up, and initial and follow-up angiographic results.
Each patient underwent computed tomography angiography (CTA) followed by digital subtraction angiography (DSA). Among the 21 aneurysms, 18 (85.7%) were detected on the CTA only, and all were identified with DSA. Four-vessel cerebral angiography, including the Alcock test, was preoperatively performed. Conventional DSA were performed. A contrast injection rate and total volume of 3 ml/s and 5 ml, respectively, were employed for the vertebral artery and the Alcock test. For the ICA, a rate and volume of 4 ml/s and 6 ml, respectively, were utilized. We classified PcomA aneurysm according to the characteristics of the PcomA and PCA (P1) seen on baseline angiography or CT angiography (CTA) as follows ( Figure 1 ): Type I was categorized as PcomA aneurysm with an absent PcomA and a normal-sized P1, type II as a hypoplastic PcomA and a normal-sized P1, type III as a normal-sized PcomA and an absent P1, type IV as a normal-sized PcomA and a hypoplastic P1, and type V as a normal-sized PcomA and a normal-sized P1. Normal size was defined when vessel diameter was similar to P2 diameter and hypoplasia was defined when vessel diameter was grossly less than P2 diameter on angiography.
All procedures were performed under intravenous sedation using propofol and alfentanyl. At the beginning of the procedure, the patient was pretreated with a heparin bolus (5000 IU) injection, followed by 1000 IU/ hour of heparin. The patient was heparinized to an activated clotting time (ACT) of 250 to 300 seconds during the procedure. Clinical follow-up ranged from two to 18 months, with a mean period of 12 months, and angiographic follow-up was performed at six months and 12 months after hospital discharge. Flow change of the initial obstructed PcomA was recorded in follow-up angiography. Bare platinum coils, the Guglielmi detachable coil (Boston Scientific, Fremont, CA, USA) and MicroPlex coil (MicroVention, Aliso Viejo, CA, USA), were used.
Brain magnetic resonance imaging (MRI) was performed when a patient displayed any neurological symptoms, such as somnolence, cranial nerve palsy, or motor weakness, or when ischemia was strongly suspected after occlusion of the PcomA.
Results
The demographic data of the study population are as follows. There were 170 patients, of whom 18 were men and 152 were women. The mean age was 60.9 years and the ages ranged from 24 to 85 years. There were 144 ruptured aneurysms and 26 unruptured aneurysms. The mean aneurysm size was 7.0 mm (range, 1.8 to 20.8 mm) and the mean size of the aneurysm neck was 3.7 mm (range, 1.2 to 7.2 mm). The most common type of PcomA was type II (56 cases, 32.9%), followed by type I (51 cases, 30.0%), type III (31 cases, 18.2%), type IV (19 cases, 11.2%), and type V (13 cases, 7.6%).
The radiological and clinical results of 21 PcomA occlusion cases are shown in Table 1 . There were two men and 19 women with a mean age of 55.7 years (range, 24 to 79 years). There were 15 ruptured aneurysms and six unruptured aneurysms. The mean aneurysm size was 7.2 mm (range, 4.0 to 12.5 mm) and the mean size of the aneurysm neck was 3.5 mm (range, 1.5 to 7.1 mm). Twelve cases were embolized completely and nine cases were embolized incompletely. Seven cases were treated by stent-assisted coiling. Among 21 cases of PcomA obstruction, 15 (71.4%) were type II PcomA aneurysms, four were type IV, two were type III, and one was type V. Thirteen cases had identifiable occlusion of PcomA on immediate angiography and eight cases had occlusion visible on follow-up angiography. Follow-up angiographies showed flow change of PcomA in 14 cases. Occlusion of PcomA became patent in six cases and patent PcomA became occluded in eight cases. Among 14 cases, two cases showed ischemic complications (Cases 9 and 18). One thalamic infarction occurred in case of change from occluded to patent flow and one cortical ischemia occurred in cases of change from patent to occluded flow. Alcock's test was performed in 14 cases and all obtained positive results. Ischemic events related to PcomA obstruction occurred in three cases (one each of type II, type III, and type IV), which included two tuberothalamic infarctions (TTIs) (types III and IV) and one cortical infarction in the territory of the PCA (type II). One of one type III patient (100%) and one of four type IV patients (25%) experienced TTIs.
Case illustration
Case 18. A 57-year-old female patient experienced a stuporous mentality with a severe headache. Brain CTA showed a normal-sized PcomA and a hypoplastic P1 (Figure 2(a) ). This is classified as type IV. During the coiling process for the aneurysm, unexpected occlusion of the PcomA occurred. After the procedure, the patient had right hemiparesis and a confused mental state (Figure 2(b) ). Brain MRI showed a left TTI (Figure 2(c) ). Although the occluded PcomA was recanalized on follow-up angiography and the hemiparesis fully recovered, her cognitive dysfunction remained ( Figure 2(d) ).
Case 9.
A 62-year-old female had a ruptured aneurysm and experienced a severe headache. Cerebral angiography and brain CTA showed a hypoplastic PcomA with a normal-sized PCA (Figure 3 This is classified as type II. Although immediate post-procedural angiography showed patent PcomA (Figure 3(d) ), a subclinical cortical infarction in the territory of the right PCA was visible on brain MRI (Figure 3 (e)). Occlusion of the PcomA was identified on follow-up angiography (Figure 3 (f)).
Case 16.
A 75-year-old female presented with decreased mentality and a clinical state of HH grade 3. A brain CT scan revealed subarachnoid hemorrhage (SAH) in the basal cistern accompanied with parenchymal hematoma in the temporal lobe (Figure 4(a) ). Brain CTA and cerebral angiography showed a type III PcomA aneurysm (Figure 4 (b) and (c)). Unexpected occlusion of the PcomA occurred ( Figure 4(d) ) and the patient experienced ischemic complications. A brain MRI scan revealed a left TTI and PCA infarction caused by the PcomA occlusion and multifocal infarction due to severe vasospasm (Figure 4(e) ).
Discussion

TTA infarction
The tuberothalamic artery (TTA), also called the polar, premamillary, or anterior thalamoperforating artery, supplies the intralaminar nucleus, ventral internal medullary lamina, and mamillothalamic tract in the paramedian thalamic area. 4 The TTA commonly arises from the middle third of the PcomA, the caudal part which is close to the PCA. 57 The number of perforating arteries arising from the PcomA is 4 to 12 (with an average of 7), each of which has a diameter between 0.1 and 0.6 mm. 7 The largest branch among these perforators has been called the TTA. 1, 8 TTI may cause wide-ranging neuropsychological deficits, such as perseverative behavior, impairment of memory, aphasia, apathy, apraxia, and impairment of planning. 9,10 An amnestic syndrome is associated with a disconnection between the anterior thalamic nuclei and hippocampal formation, caused by the disruption of the mamillothalamic tract. 5, 11 Also, initial transient or mild contralateral hemiparesis is thought to be caused by the compression of the internal capsule by post-ischemic edema. 5 The prognosis after TTA infarction is generally favorable in terms of a robust recovery from motor deficits. 10 However, cognitive deficits are more often permanent and are associated with an unfavorable prognosis. 12 Physiologically, isolated infarctions involving the TTA are very rare and small vessel occlusion is the most common mechanism of such infarctions. 4 Sometimes, infarction may be caused by thromboembolism, either from the carotid or vertebrobasilar arterial systems. 5, 9, 13 However, in cases of ischemic events after PcomA compromise from coil embolization, two mechanisms can be involved. One is hemodynamic hypoperfusion, 1, 2, 14 and the other is a thromboembolic event. 14 Out of 21 cases, 14 underwent flow change in the PcomA. We identified that unexpected flow change of PcomA occurs in a relatively large number of cases. Flow changes can cause a thromboembolism in the TTA or distal PCA. Among three cases with ischemic complications, flow change in the PcomA was identified on follow-up angiography in two cases. One patient experienced TTA infarction and the flow pattern changed from occlusion to recanalization of the PcomA. We presume that a hemodynamic state or thromboembolism may have been involved, either separately or together, in this case. Another case had a subclinical cortical infarction and the flow pattern changed from patent PcomA to occlusion. Thromboembolism may have been the main cause of the flow change in the PcomA. Although one case had type III PcomA and did not receive follow-up angiography, we can be sure that hemodynamic compromise resulted in ischemia because a brain MRI scan showed an infarction of the territory of the PCA, including TTI. Treatment strategies of PcomA aneurysm according to type Type I. Reports of brain autopsies found that the PcomA was absent in 1%3% of cases. 15, 16 However, among a total of 170 cases, type I aneurysms made up 51 cases (30.0%). This discrepancy most likely arose from the fact that an invisible PcomA on angiography does not indicate an absence of a PcomA and might rather indicate a low or absent hemodynamic role of the PcomA. Also, depending on a patient's hemodynamic conditions (especially in ruptured cases) or details having to do with angiographic equipment, such as the location and types of catheter used or protocols used for contrast media injection, the angiographic characteristics of the PcomA could be altered.
In autopsy studies on a normal population, the PcomA is invariably present, although it may not be visible on radiological images. 7, 17 Also, the diameter of the PcomA is not related to the mean number, diameter, length, or distribution of the penetrating vessels. 18, 19 Thus, some authors have suggested that TTA infarction is possible even if the PcomA cannot be seen on imaging studies. 4 In our study, there were no thalamic infarctions in cases of type I aneurysm. However, physicians should pay attention to maintaining optimal antithrombotic conditions during the procedure to prevent unexpected embolic phenomena.
Type II. Type II PcomA comprises the type of PcomA commonly referred to as ''adult-type PcomA.'' In type II PcomA, P1 and P2 have similar sizes. Although there is controversy regarding the definition of ''hypoplasia'' and some authors consider hypoplasia to occur when the diameter of a vessel is less than 1.0 to 1.5 mm, 15, 20, 21 we defined angiographic hypoplasia when the vessel diameter was less than the diameter of the PCA (P2) because we placed emphasis on the hemodynamic environment between the PcomA and PCA (P1 and P2), which is likely to play a major role in ischemic complications. In reports of brain autopsies, a hypoplastic PcomA was observed in 13.2%24% of cases. 15, 16 In our study, type II aneurysms accounted for 56 cases (32.9%), making them the most common. Among them, we identified 15 cases of PcomA obstruction and only one case (Case 9) had ischemic complications, cortical embolic infarction, and there was no clinically significant thalamic infarction. Interestingly, immediate angiography showed patent PcomA with a completely embolized aneurysm in Case 9 and PcomA obstruction was identified on follow-up angiography. Thrombosis around the coil mass and PcomA during obstruction of the PcomA is likely to have been caused by cortical infarction. Cho et al. 14 reported a thalamic infarction after incomplete coil compromise of a hypoplastic PcomA and suggested that incomplete coil compromise of the PcomA may be a source of delayed thromboembolic infarction. Also, they reported that there were no ischemic complications in 23 patients with PcomA aneurysms who had hypoplastic PcomAs. Sacrifice of the PcomA may be relatively safe in patients with type II aneurysm. From a surgical perspective, this information might be more useful when the origin of the PcomA is concealed behind the aneurysm in the surgical field. We suggest two mechanisms of preventing TTA infarction even when there is occlusion of flow in the PcomA. One is compensatory retrograde flow from the vertebrobasilar system. A type II P1 has a diameter larger than the PcomA, so the blood supply to the occipital lobe is mainly provided by the vertebrobasilar system. 22 Otherwise, the TTA has an anatomically complementary relationship with the paramedian artery originating from the P1 segment. 5 Sometimes, the territory of the TTA might be supplied by the perforating artery from the PCA. 23 Types III and IV. Type III and IV PcomA are commonly called ''fetal PCA,'' ''embryonic PcomA,'' or ''primitive PcomA.'' In such cases, there is an absence of P1 (type III) or a hypoplastic P1 (type IV). 16, 24, 25 Hypoplasticity of the proximal segment of the PCA is often reported and is explained by differential development. On account of hemodynamic factors, the proximal part of the embryonic PCA up to its division becomes smaller in caliber and is then recognized as the PcomA. 16 In a previous autopsy study, the PcomA being a part of the persistent fetal circulation and aplasia of the first segment of the PCAs was identified in 0.5% of cases 15 and a hypoplastic PCA was seen in 10.6% of cases. 16 In our study, type III PCA accounted for 31 cases (18.2%) and type IV PCA accounted for 19 cases (11.2%). This discrepancy might be caused by hemodynamic predominance between the PcomA and P1, as previously described. A case of obstruction (100%) of type III PcomA and one case of obstruction (25%) of four type IV PcomAs resulted in TTI. We classified five types of PcomA aneurysm according to the characteristics of cerebral angiography on baseline angiographies, CTA or DSA, and consider that this may reflect the actual hemodynamic flow around the PcomA and P1. A negative P1 segment suggests fetal variant PCA, which can roughly be defined as a variant exhibiting primary perfusion of the PCA from the ICA and minimal perfusion of the PCA from the vertebrobasilar system, often with an absent or hypoplastic P1 segment. 26 Compared to a type I, II and V P1, a type III or a type IV P1 might be less functional or have a minimal hemodynamic state. This means that the hemodynamic function of a type III or type IV P1 might be insufficient to compensate when loss of PcomA flow occurs, even when retrograde flow is confirmed on angiography, which is called Alcock's test. Of the same opinion, Endo et al. 1 suggested that a positive Alcock's test with negative visualization of the P1 segment corresponds to the fetal variant of PCA with a hypoplastic P1 segment, and results in tuberothalamic artery infarctions without cortical lesions. Also, they recommended that greater PcomA/P1 ratios predict thalamic infarction after PcomA sacrifice. We identified that TTI occurred even in case of positive visualization of the P1 segment (type IV, Case 18). We think that positive visualization of P1 might not be a safe indicator of PcomA obstruction sometimes and PcomA/P1 ratio might be considered as an affecting factor of thalamic infarction in this case. Unfortunately, we could not confirm those authors' opinions about Alcock's test in our study because two cases of TTI did not undergo the procedure before the treatment. However, we believe that Alcock's test is not particularly relevant to TTI after occlusion of the PcomA.
Type V. Type V PcomA has been called a transitional configuration of the PcomA, and is defined when the PcomA is equal in diameter to the P1 segment of the PCA. 22 In such cases, the PCA appears to originate partly from the PcomA and partly from the basilar artery. 16 In our population, type V aneurysms occurred in 13 cases (7.6%). Among them, one type V PcomA patient was occluded and had no ischemic complications. However, physicians should take notice of unexpected thromboembolisms and take care to maintain an optimal antithrombotic level. Maintaining the patency of the PcomA is most likely the best means of ensuring successful treatment.
The present study has some limitations. First, it was performed using a retrospective chart review. Also, only aneurysm cases were enrolled in our study, not a normal population. This situation may increase the risk of selection bias. Second, the number of patients enrolled in this study is too small for the conclusions to be statistically significant. A future study with a larger number of patients is needed to establish optimal treatment strategies. Despite these limitations, when physicians encounter situations similar to those described herein, our descriptions may provide guidance in selecting a treatment modality.
Conclusion
Decision making according to the hemodynamic characteristics of the PcomA and PCA is necessary to avoid ischemic complications when treating PcomA aneurysms. It may be relatively safe to sacrifice a type II PcomA if necessary. However, physicians should pay attention to unexpected flow change, such as recanalization or occlusion of the PcomA, which is possible after treatment. Positive visualization of P1 might not be a safe indicator of PcomA obstruction. Maintaining patency of the PcomA is the best means of successful treatment.
